ClinicalTrials.Veeva

Menu

Effect of Perioperative Sivelstat Administration for Liver Resection (KMS)

K

Kochi University

Status

Completed

Conditions

Liver Diseases

Treatments

Drug: sivelstat
Drug: glucose

Study type

Interventional

Funder types

Other

Identifiers

NCT00738348
Kochi University
ESAR

Details and patient eligibility

About

It is reported that sivelstat improved and preserved the postoperative renal function in the orthopedic management. Moreover because sivelstat reduced the migration of neutrophil, it improved acute lung injury. During liver resection, Pringle maneuver, clamping the hepatoduodenal ligament, was performed. Pringle maneuver causes reperfusion injury of the liver. We have a hypothesis that sivelstat prevent the warm shock of reperfusion injury of the liver by Pringle maneuver.

Full description

Whether the incidence of postoperative morbidities, such as liver failure, renal failure, or congestive heart failure, was reduced by administration of perioperative sivelstat.

Enrollment

50 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • liver disease which surgical management was indicated

Exclusion criteria

  • weight loss greater than 10 per cent during the previous 6 months, signs of distant metastasis, or of respiratory, renal or heart disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Triple Blind

50 participants in 2 patient groups, including a placebo group

2
Active Comparator group
Description:
250mL of 5% glucose plus 300mg of sivelstat was infected through the vein at 10mL per an hour
Treatment:
Drug: sivelstat
1
Placebo Comparator group
Description:
250mL of 5% glucose was injected though the vein at 10mL per an hour
Treatment:
Drug: glucose

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems